ATE106753T1 - Gegenstand für die transdermale applikation von estradiol und verfahren zur herstellung eines solchen gegenstandes. - Google Patents

Gegenstand für die transdermale applikation von estradiol und verfahren zur herstellung eines solchen gegenstandes.

Info

Publication number
ATE106753T1
ATE106753T1 AT90312435T AT90312435T ATE106753T1 AT E106753 T1 ATE106753 T1 AT E106753T1 AT 90312435 T AT90312435 T AT 90312435T AT 90312435 T AT90312435 T AT 90312435T AT E106753 T1 ATE106753 T1 AT E106753T1
Authority
AT
Austria
Prior art keywords
article
estradiol
making
transdermal application
transdermal
Prior art date
Application number
AT90312435T
Other languages
English (en)
Inventor
Francisco Jose Evarist Stefano
Jose Adrian Nowogrodski
Dario Norberto Ramon Carrara
Original Assignee
Beta Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3478739&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE106753(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beta Pharm Co filed Critical Beta Pharm Co
Application granted granted Critical
Publication of ATE106753T1 publication Critical patent/ATE106753T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT90312435T 1989-11-17 1990-11-14 Gegenstand für die transdermale applikation von estradiol und verfahren zur herstellung eines solchen gegenstandes. ATE106753T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AR89315479A AR246186A1 (es) 1989-11-17 1989-11-17 Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica.

Publications (1)

Publication Number Publication Date
ATE106753T1 true ATE106753T1 (de) 1994-06-15

Family

ID=3478739

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90312435T ATE106753T1 (de) 1989-11-17 1990-11-14 Gegenstand für die transdermale applikation von estradiol und verfahren zur herstellung eines solchen gegenstandes.

Country Status (9)

Country Link
EP (1) EP0430491B2 (de)
JP (1) JPH03227920A (de)
AR (1) AR246186A1 (de)
AT (1) ATE106753T1 (de)
BR (1) BR9005908A (de)
DE (1) DE69009697T3 (de)
DK (1) DK0430491T4 (de)
ES (1) ES2057442T5 (de)
MX (1) MX171907B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4210165A1 (de) * 1991-07-30 1993-02-04 Schering Ag Transdermale therapeutische systeme
JP2960832B2 (ja) * 1992-05-08 1999-10-12 ペルマテック テクノロジー アクチェンゲゼルシャフト エストラジオールの投与システム
DE4237453C1 (de) * 1992-11-06 1993-08-19 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE4400770C1 (de) * 1994-01-13 1995-02-02 Lohmann Therapie Syst Lts Wirkstoffhaltiges Pflaster zur Abgabe von Estradiol mit mindestens einem Penetrationsverstärker, Verfahren zu seiner Herstellung und seine Verwendung
GR1002079B (en) * 1994-07-26 1995-12-05 Lavipharm A E System of a special structure and composition for the rapid transdermal administration of oestrogens.
DE4429667C2 (de) * 1994-08-20 1996-07-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
GB9720470D0 (en) 1997-09-25 1997-11-26 Ethical Pharmaceuticals South Inhibition of crystallization in transdermal devices
US5968919A (en) * 1997-10-16 1999-10-19 Macrochem Corporation Hormone replacement therapy drug formulations for topical application to the skin
DE19815060A1 (de) * 1998-04-03 1999-10-14 Jenapharm Gmbh Pharmazeutische Präparate zur Therapie von Nebenwirkungen während und/oder nach einer GnRHa-Therapie
SE9801704D0 (sv) 1998-05-14 1998-05-14 Bioglan Ab Biologically active composition
DE10003397A1 (de) 2000-01-27 2001-08-09 Hartmann Paul Ag Polyelektrolyt-Feststoffsystem, Verfahren zur Herstellung desselben sowie Wundverband
DE10019171A1 (de) * 2000-04-07 2001-10-18 Schering Ag Zusammensetzungen zur Verwendung als Penetrationsverstärker in transdermalen Formulierungen für hoch lipophile Wirkstoffe

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4764381A (en) * 1985-12-06 1988-08-16 Key Pharmaceuticals, Inc. Percutaneous penetration enhancer of oleic acid and 2-ethyl-1, 3-hexanediol
US4908389A (en) * 1986-08-27 1990-03-13 Warner-Lambert Company Penetration enhancement system
US4994267A (en) † 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Transdermal acrylic multipolymer drug delivery system
IL92496A0 (en) * 1988-12-01 1990-08-31 Schering Corp Compositions for transdermal delivery of estradiol

Also Published As

Publication number Publication date
EP0430491A3 (en) 1991-12-27
EP0430491A2 (de) 1991-06-05
JPH03227920A (ja) 1991-10-08
EP0430491B1 (de) 1994-06-08
ES2057442T5 (es) 2001-02-16
DK0430491T4 (da) 2001-01-02
ES2057442T3 (es) 1994-10-16
BR9005908A (pt) 1991-09-24
AR246186A1 (es) 1994-07-29
DE69009697D1 (de) 1994-07-14
DE69009697T2 (de) 1994-12-22
EP0430491B2 (de) 2000-10-25
DK0430491T3 (da) 1994-09-19
DE69009697T3 (de) 2001-02-22
MX171907B (es) 1993-11-23

Similar Documents

Publication Publication Date Title
DE69127609D1 (de) Vorrichtung und verfahren zur herstellung von diamanten
DE69030596D1 (de) Verfahren und Vorrichtung zur Behandlung von Proben
DE69027384D1 (de) Beta-Oligosaccharide enthaltende Zusammensetzung und Verfahren zur Verbesserung der Darmflora
DE69422086D1 (de) Verfahren und Vorrichtung zur Herstellung von Brot
DE69034098D1 (de) Katalytisches Verfahren zur Hydrierung und/oder Dehydrierung
ATE96174T1 (de) Verfahren zur herstellung von avermectine-b und die verwendeten kulturen.
ATE113968T1 (de) Polymere verdickungsmittel und verfahren zur herstellung.
ATE66927T1 (de) Verfahren zur herstellung von chemisch definierten und reproduzierbaren polydeoxyribonukleotiden.
DE69011951D1 (de) Verfahren zur Behandlung und Herstellung von Material.
ATE106753T1 (de) Gegenstand für die transdermale applikation von estradiol und verfahren zur herstellung eines solchen gegenstandes.
DE59500700D1 (de) Verfahren und Mittel zur Herstellung von purpurfarbenen Dekoren
DE69124218D1 (de) Verfahren und Vorrichtung zur Herstellung von Metallzusammensetzungen in halbfestem Zustand
DE68912187D1 (de) Zusammensetzung für und Verfahren zur Leimung.
DE69007418D1 (de) Octadienyläther und verfahren zur herstellung von octadienyläthern.
DE59001670D1 (de) Verfahren und anlage zur herstellung von dicalciumphosphat.
DE69020188D1 (de) Sterilisiermischung und Verfahren zur Sterilisierung.
DE69030836D1 (de) Material und Verfahren zur Herstellung von Mikromustern
DE68917372D1 (de) Verfahren zur Herstellung von Nde I-Restriktionsendonuklease und Methylase.
DE69011795D1 (de) Benzoxazinyl-Pyrazole und Verfahren zur Herstellung und Anwendung.
DE59308906D1 (de) Verfahren und Vorrichtung zur Herstellung von Schokoladenartikeln
DE58908727D1 (de) Verfahren für eine sterile Handhabung von strömungsfähigen Fermenterproben sowie Vorrichtung zur Durchführung des Verfahrens.
DE59101473D1 (de) Verfahren zur Herstellung von N-aryl-substituierten 2-Aminoalkyl-2-hydroxy-alkylaminen und N-arylsubstituierten Piperazinen.
DE69016073D1 (de) Verfahren zur Herstellung eines Kristalls und Kristallkörpers.
DE68927174D1 (de) Verfahren zur herstellung von weichem stahlmaterial
DE69023681D1 (de) Verfahren zur Herstellung von Restriktionsendonuklease und -Methylase-MwoI.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee